Ossiam Has $143,000 Holdings in Ryan Specialty Holdings, Inc. (NYSE:RYAN)

by · The Markets Daily

https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?w=250&h=150&zc=2&src=https://www.marketbeat.com/logos/ryan-specialty-holdings-inc-logo.jpg?v=20221107155854
Ossiam raised its stake in Ryan Specialty Holdings, Inc. (NYSE:RYANFree Report) by 66.1% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,191 shares of the company’s stock after acquiring an additional 1,270 shares during the quarter. Ossiam’s holdings in Ryan Specialty were worth $143,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Dfpg Investments LLC grew its position in shares of Ryan Specialty by 1.4% during the 2nd quarter. Dfpg Investments LLC now owns 18,610 shares of the company’s stock worth $841,000 after buying an additional 250 shares during the period. Treasurer of the State of North Carolina grew its position in shares of Ryan Specialty by 0.7% during the 1st quarter. Treasurer of the State of North Carolina now owns 35,957 shares of the company’s stock worth $1,447,000 after buying an additional 260 shares during the period. Keybank National Association OH grew its position in shares of Ryan Specialty by 3.3% during the 1st quarter. Keybank National Association OH now owns 8,220 shares of the company’s stock worth $331,000 after buying an additional 260 shares during the period. Torray Investment Partners LLC grew its position in shares of Ryan Specialty by 0.7% during the 2nd quarter. Torray Investment Partners LLC now owns 39,009 shares of the company’s stock worth $1,751,000 after buying an additional 290 shares during the period. Finally, Ensign Peak Advisors Inc grew its position in shares of Ryan Specialty by 1.2% during the 1st quarter. Ensign Peak Advisors Inc now owns 24,690 shares of the company’s stock worth $994,000 after buying an additional 300 shares during the period. Institutional investors and hedge funds own 34.09% of the company’s stock.

Insider Buying and Selling at Ryan Specialty

In other Ryan Specialty news, Director David P. Bolger sold 10,580 shares of Ryan Specialty stock in a transaction that occurred on Monday, November 13th. The shares were sold at an average price of $44.58, for a total value of $471,656.40. Following the transaction, the director now owns 85,204 shares of the company’s stock, valued at $3,798,394.32. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 54.51% of the company’s stock.

Ryan Specialty Stock Performance

Shares of RYAN opened at $45.03 on Wednesday. The company has a debt-to-equity ratio of 2.07, a quick ratio of 1.20 and a current ratio of 1.20. Ryan Specialty Holdings, Inc. has a twelve month low of $35.10 and a twelve month high of $50.64. The firm’s 50 day moving average price is $45.98 and its two-hundred day moving average price is $45.33. The firm has a market cap of $11.72 billion, a P/E ratio of 95.81 and a beta of 0.47.

Ryan Specialty (NYSE:RYANGet Free Report) last announced its quarterly earnings results on Thursday, November 2nd. The company reported $0.32 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.32. Ryan Specialty had a net margin of 9.18% and a return on equity of 42.39%. The firm had revenue of $501.94 million for the quarter, compared to analyst estimates of $500.92 million. On average, analysts forecast that Ryan Specialty Holdings, Inc. will post 1.38 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several brokerages have recently commented on RYAN. Wolfe Research began coverage on shares of Ryan Specialty in a research report on Thursday, September 21st. They set an “outperform” rating and a $59.00 price target for the company. Citigroup boosted their price objective on shares of Ryan Specialty from $48.00 to $49.00 and gave the company a “neutral” rating in a report on Tuesday, October 10th. JMP Securities assumed coverage on shares of Ryan Specialty in a report on Tuesday, September 19th. They set a “market perform” rating for the company. BMO Capital Markets cut shares of Ryan Specialty from an “outperform” rating to a “market perform” rating and decreased their price objective for the company from $53.00 to $49.00 in a report on Monday, October 30th. Finally, The Goldman Sachs Group cut shares of Ryan Specialty from a “buy” rating to a “neutral” rating and decreased their price objective for the company from $57.00 to $53.00 in a report on Monday, November 20th. Four research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $51.14.

Get Our Latest Stock Report on Ryan Specialty

About Ryan Specialty

(Free Report)

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.

See Also

Want to see what other hedge funds are holding RYAN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ryan Specialty Holdings, Inc. (NYSE:RYANFree Report).